Literature DB >> 10913806

Power calculation for clinical trials when the outcome is a composite ranking of survival and a nonfatal outcome.

R P McMahon1, F E Harrell.   

Abstract

In a clinical trial in which mortality occurs and a nonfatal outcome is measured after a fixed duration of follow-up, composite rank scores in which deaths (ranked by survival time) are scored below ranks for the nonfatal outcome have been proposed to test for treatment efficacy. This report derives formulae for calculating power for such a rank test under the conservative assumption that the treatment has a beneficial effect on the nonfatal outcome but no effect on mortality.

Mesh:

Year:  2000        PMID: 10913806     DOI: 10.1016/s0197-2456(00)00052-0

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  5 in total

1.  Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations.

Authors:  Roland A Matsouaka; Rebecca A Betensky
Journal:  Stat Med       Date:  2014-11-13       Impact factor: 2.373

2.  An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.

Authors:  Roland A Matsouaka; Aneesh B Singhal; Rebecca A Betensky
Journal:  Stat Methods Med Res       Date:  2016-12-29       Impact factor: 3.021

3.  Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT): Design of a Phase IIb, placebo-controlled, double-blind, randomized clinical trial of doxycycline for the reduction of growth of small abdominal aortic aneurysm.

Authors:  B Timothy Baxter; Jon Matsumura; John Curci; Ruth McBride; William C Blackwelder; Xinggang Liu; LuAnn Larson; Michael L Terrin
Journal:  Contemp Clin Trials       Date:  2016-03-25       Impact factor: 2.226

4.  Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.

Authors:  Sumeet Subherwal; Kevin J Anstrom; William S Jones; Michael G Felker; Sanjay Misra; Michael S Conte; William R Hiatt; Manesh R Patel
Journal:  Am Heart J       Date:  2012-09       Impact factor: 4.749

5.  Sample size formula for general win ratio analysis.

Authors:  Lu Mao; KyungMann Kim; Xinran Miao
Journal:  Biometrics       Date:  2021-06-08       Impact factor: 1.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.